메뉴 건너뛰기




Volumn 341, Issue 10, 2006, Pages 1253-1265

Semi-synthetic heparin derivatives: chemical modifications of heparin beyond chain length, sulfate substitution pattern and N-sulfo/N-acetyl groups

Author keywords

Glycosaminoglycans; Heparin; Heparin analogs; Heparinoids; Semi synthesis

Indexed keywords

BIOSYNTHESIS; COAGULATION; NEGATIVE IONS; POLYSACCHARIDES; POSITIVE IONS; PROTEINS; REDUCTION;

EID: 33646915292     PISSN: 00086215     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carres.2006.04.014     Document Type: Short Survey
Times cited : (40)

References (209)
  • 1
    • 0038792320 scopus 로고    scopus 로고
    • Many reviews have discussed the structure of heparin and HS. For example, see:
    • Many reviews have discussed the structure of heparin and HS. For example, see:. Linhardt R.J. J. Med. Chem. 46 (2003) 2551-2564
    • (2003) J. Med. Chem. , vol.46 , pp. 2551-2564
    • Linhardt, R.J.1
  • 11
    • 0036139068 scopus 로고    scopus 로고
    • Hundreds of reviews and manuscripts describe therapeutic potential of heparin, HS and/or their polyanionic mimics to bind HS-binding proteins and block or modulate specific HS-mediated biological processes. For select reviews covering some areas of interest, see Cellular communication and host-pathogen recognition:
    • Hundreds of reviews and manuscripts describe therapeutic potential of heparin, HS and/or their polyanionic mimics to bind HS-binding proteins and block or modulate specific HS-mediated biological processes. For select reviews covering some areas of interest, see Cellular communication and host-pathogen recognition:. Liu J., and Thorp S.C. Med. Res. Rev. 22 (2002) 1-25
    • (2002) Med. Res. Rev. , vol.22 , pp. 1-25
    • Liu, J.1    Thorp, S.C.2
  • 20
    • 0004247250 scopus 로고    scopus 로고
    • Witczak Z.B., and Nieforth K.A. (Eds), Marcel Dekker, New York
    • Linhardt R.J., and Toida T.T. In: Witczak Z.B., and Nieforth K.A. (Eds). Carbohydrates as Drugs (1996), Marcel Dekker, New York
    • (1996) Carbohydrates as Drugs
    • Linhardt, R.J.1    Toida, T.T.2
  • 28
    • 0346100658 scopus 로고    scopus 로고
    • For general reviews that discuss manipulation of heparin and heparin-like oligosaccharide chain length and sulfate substitution pattern, see Ref. 5. For recent examples regarding modification of heparin and HS sulfate substitution and/or structure, see:
    • For general reviews that discuss manipulation of heparin and heparin-like oligosaccharide chain length and sulfate substitution pattern, see Ref. 5. For recent examples regarding modification of heparin and HS sulfate substitution and/or structure, see:. Yates E.A., Guimond S.E., and Turnbull J.E. J. Med. Chem. 47 (2004) 277-280
    • (2004) J. Med. Chem. , vol.47 , pp. 277-280
    • Yates, E.A.1    Guimond, S.E.2    Turnbull, J.E.3
  • 31
    • 0036328332 scopus 로고    scopus 로고
    • For examples of non-carbohydrate-based structures prepared as ligands for heparin-binding proteins, see:
    • For examples of non-carbohydrate-based structures prepared as ligands for heparin-binding proteins, see:. Benezra M., Ishai-Michaeli R., Ben-Sasson S.A., and Vlodavsky I. J. Cell Phys. 192 (2002) 276-285
    • (2002) J. Cell Phys. , vol.192 , pp. 276-285
    • Benezra, M.1    Ishai-Michaeli, R.2    Ben-Sasson, S.A.3    Vlodavsky, I.4
  • 40
    • 33646915150 scopus 로고    scopus 로고
    • Huang, L. Ph.D. Thesis, Wayne State University, 2003.
  • 41
    • 4544280219 scopus 로고    scopus 로고
    • These agents and future prospects have recently been reviewed, see:
    • These agents and future prospects have recently been reviewed, see:. Petitou M., and van Boeckel C.A.A. Angew. Chem., Int. Ed. 43 (2004) 3118-3133
    • (2004) Angew. Chem., Int. Ed. , vol.43 , pp. 3118-3133
    • Petitou, M.1    van Boeckel, C.A.A.2
  • 42
    • 10844229062 scopus 로고    scopus 로고
    • For recent reports describing synthesis of heparin and HS oligosaccharide sequences, see:
    • For recent reports describing synthesis of heparin and HS oligosaccharide sequences, see:. Rele S.M., Iyer S.S., Baskaran S., and Chaikof E.L. J. Org. Chem. 69 (2004) 9159-9170
    • (2004) J. Org. Chem. , vol.69 , pp. 9159-9170
    • Rele, S.M.1    Iyer, S.S.2    Baskaran, S.3    Chaikof, E.L.4
  • 49
    • 33646946959 scopus 로고    scopus 로고
    • Velluz, L.; Nomine, G.; Pierdez, A.; Rosseau, G.; Penasse, L., U.S. Patent 3,065,140, 1962.
  • 50
    • 33646898691 scopus 로고    scopus 로고
    • Cushing, I. B. U.S. Patent 31,188,116, 1964.
  • 51
    • 33646920817 scopus 로고    scopus 로고
    • Roussel-UCLAF, U.S. Patent 3,232,838, 1964.
  • 103
    • 33646940633 scopus 로고    scopus 로고
    • Mardiguian, J. S. U.S. Patent 4,440,926, 1984.
  • 104
    • 33646925052 scopus 로고    scopus 로고
    • Debrie, R. U.S. Patent 5,389,618, 1995.
  • 106
    • 33646920805 scopus 로고    scopus 로고
    • Nomine, G.; Bucourt, R. U.S. Patent 3,232,837, 1966.
  • 128
    • 33646925311 scopus 로고    scopus 로고
    • Foley, K. M.; Griffin, C. C.; Amaya, E., Eur. Pat. Appl. 873072920, 1988.
  • 129
    • 33646932888 scopus 로고    scopus 로고
    • Mardiguian, J., Fr. Pat. Appl. 2100735, 1972.
  • 130
    • 33646912940 scopus 로고    scopus 로고
    • Ohtsu, A.; Yamagami, E.; Tomibe, K., Jap. Pat. Appl. 52.111983, 1978.
  • 136
    • 33646912131 scopus 로고    scopus 로고
    • Nakaya, T., JP 11080187, 1999.
  • 153
    • 33646926903 scopus 로고    scopus 로고
    • Brandley, B. K.; James, P. G.; Tiemeyer, M. U.S. Patent 5,094,731, 1992.
  • 186
    • 33646947229 scopus 로고    scopus 로고
    • Brenchley, P. E. C. WO 00/77241 A2, 2000.
  • 208
    • 33646924770 scopus 로고    scopus 로고
    • Griffin, C.C.; Foley, K.M.; Amaya, E. U.S. Patent 4,745,105, 1988.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.